UCB PHARMA

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2025-07-22",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad -22/07/2025 - Annexes du Moniteur belge",
      "value": "22/07/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-07-11",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 114 JULI 2025",
      "value": "11/07/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-04-23",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 23 APRIL 2025",
      "value": "23/04/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "Onderwerp akte: Benoeming bestuurders - wijziging delegatiereglement dagelijks bestuur",
      "value": "wijziging delegatiereglement dagelijks bestuur",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-06-11",
      "type": "general_meeting",
      "quote": "GEWONE ALGEMENE VERGADERING VAN 11 JUNI 2025",
      "value": "11/06/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-06-11",
      "type": "officer_appointment",
      "quote": "Benoeming van: Almirall N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2025-06-11"
      },
      "object": null,
      "subject": "e2",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "11/06/2025"
      }
    },
    {
      "date": "2025-06-11",
      "type": "officer_appointment",
      "quote": "Benoeming van: Novo Nordisk Pharma N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2025-06-11"
      },
      "object": null,
      "subject": "e3",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "11/06/2025"
      }
    },
    {
      "date": "2025-06-11",
      "type": "officer_appointment",
      "quote": "Benoeming van: Takeda Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2025-06-11"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "11/06/2025"
      }
    },
    {
      "date": "2025-06-11",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. Amgen N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2025-06-11"
      },
      "object": null,
      "subject": "e5",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "11/06/2025"
      }
    },
    {
      "date": "2025-06-11",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. MSD Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2025-06-11"
      },
      "object": null,
      "subject": "e6",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "11/06/2025"
      }
    },
    {
      "date": "2025-06-11",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3. Roche N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2025-06-11"
      },
      "object": null,
      "subject": "e7",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "11/06/2025"
      }
    },
    {
      "date": "2025-06-11",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4. UCB Pharma N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2025-06-11"
      },
      "object": null,
      "subject": "e8",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "11/06/2025"
      }
    },
    {
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Vertex Pharmaceuticals (Netherlands) BV",
      "value": {
        "role": "bestuurder",
        "end_date": "2025-06-11"
      },
      "object": null,
      "subject": "e9",
      "_value_raw": {
        "role": "bestuurder",
        "reason": "ontslag",
        "end_date": "11/06/2025"
      }
    },
    {
      "date": "2025-05-16",
      "type": "permanent_representative",
      "quote": "Bristol-Myers Squibb Belgium N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 16/05/2025 de heer Paul Lacante",
      "value": {
        "start_date": "16/05/2025"
      },
      "object": "e10",
      "subject": "e11"
    },
    {
      "type": "permanent_representative",
      "quote": "Almirall N.V. ... heeft als vaste vertegenwoordiger de heer Gregory Paton",
      "value": {},
      "object": "e2",
      "subject": "e13"
    },
    {
      "type": "permanent_representative",
      "quote": "Novo Nordisk Pharma N.V. ... heeft als vaste vertegenwoordiger de heer Axel De Muyt",
      "value": {},
      "object": "e3",
      "subject": "e14"
    },
    {
      "type": "permanent_representative",
      "quote": "Takeda Belgium N.V. ... heeft als vaste vertegenwoordiger de heer Bruno Rabilier",
      "value": {},
      "object": "e4",
      "subject": "e15"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 9714,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Kantersteen 47, 1000 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.090.131",
      "kind": "company",
      "name": "Almirall N.V.",
      "attrs": {
        "seat": "Lenneke Marelaan 4, 1932 Sint-Stevens-Woluwe"
      }
    },
    {
      "id": "e3",
      "kbo": "0414.695.586",
      "kind": "company",
      "name": "Novo Nordisk Pharma N.V.",
      "attrs": {
        "seat": "Alfons Gossetlaan 32E/202, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e5",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen N.V.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e6",
      "kbo": "0406.820.770",
      "kind": "company",
      "name": "MSD Belgium N.V.",
      "attrs": {
        "seat": "Vorstlaan 25, 1170 Watermaal-Bosvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.088.151",
      "kind": "company",
      "name": "Roche N.V.",
      "attrs": {
        "seat": "Dantestraat 75, 1070 Anderlecht"
      }
    },
    {
      "id": "e8",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {
        "seat": "Researchdreef 60, 1070 Anderlecht"
      }
    },
    {
      "id": "e9",
      "kbo": "0666.408.905",
      "kind": "company",
      "name": "Vertex Pharmaceuticals (Netherlands) BV",
      "attrs": {
        "seat": "Leidsevaart 20, NL - 2013 HA Haarlem"
      }
    },
    {
      "id": "e10",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Paul Lacante",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Sally McNab",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Gregory Paton",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Axel De Muyt",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Bruno Rabilier",
      "attrs": {}
    },
    {
      "id": "e16",
      "kbo": null,
      "kind": "company",
      "name": "Facing BV",
      "attrs": {}
    },
    {
      "id": "e17",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "S\u00E9bastien Schueremans",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "de nommer Mazars Bedrijfsrevisorer - R\u00E9viseurs d\u0027Entreprises BV/SRL, commissaire aux comptes, dont le mandat expire \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de 2024 pour une dur\u00E9e de 3 ans, jusqu\u0027\u00E0 et y compris l\u0027assembl\u00E9e g\u00E9n\u00E9rale annuelle de 2027"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Myriam Juckler",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-07-26",
      "evidence_quote": "Le Conseil d\u0027Administration a d\u00E9cid\u00E9 d\u0027approuver la nomination de Myriam Juckler, avec effet \u00E0 ce jour, avec adresse professionnelle, Chemin du Foriest 1 \u00E0 1420 Braine-l\u0027Alleud, en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9e charg\u00E9e de la gestion journali\u00E8re de la soci\u00E9t\u00E9"
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Jacques Marbehant",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-07-26",
      "evidence_quote": "en remplacement de Jacques Marbehant dont les pouvoirs ont \u00E9t\u00E9 r\u00E9voqu\u00E9s \u00E0 ce jour"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Christophe Tellier",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "de renouveler les mandats d\u0027administrateurs de Messieurs Jean-Christophe Tellier et Charl van Zyl pour un terme de six ans"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Charl van Zyl",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "de renouveler les mandats d\u0027administrateurs de Messieurs Jean-Christophe Tellier et Charl van Zyl pour un terme de six ans"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Charl van Zyl",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-07-01",
      "evidence_quote": "Les Actionnaires actent la d\u00E9mission de Chari van Zyl en qualit\u00E9 d\u0027administrateur avec effet au 1 juillet 2023."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Benoeming bestuurders en commissaris - Nieuwe vaste vertegenwoordigers van bestuurders - Benoeming voorzitter",
      "value": "Benoeming bestuurders en commissaris - Nieuwe vaste vertegenwoordigers van bestuurders - Benoeming voorzitter",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-05-03",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 03 MEI 2023",
      "value": "03/05/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "general_meeting",
      "quote": "GEWONE ALGEMENE VERGADERING VAN 22 MAART 2023",
      "value": "22/03/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AstraZeneca N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3.GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4.Janssen-Cilag N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 5.Novartis Pharma N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 6.Sanofi Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "auditor_appointment",
      "quote": "De Algemene Vergadering bevestigt de herbenoeming voor een periode van drie jaar van de commissaris KPMG Bedrijfsrevisoren BV",
      "value": {
        "role": "commissaris",
        "term": "drie jaar",
        "start_date": "22/03/2023"
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "date": "2023-01-01",
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 01/01/2023 de heer Xavier Hormaechea",
      "value": {
        "start_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2023-01-19",
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. ... heeft als nieuwe vaste vertegenwoordiger vanat 19/01/2023 mevrouw Emmanuelle Boishardy",
      "value": {
        "start_date": "19/01/2023"
      },
      "object": "e4",
      "subject": "e12"
    },
    {
      "date": "2023-04-19",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 19 APRIL 2023",
      "value": "19/04/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-04-19",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 19 april 2023 werd de heer Fr\u00E9d\u00E9ric Clais tot voorzitter van de Raad van Bestuun benoemd.",
      "value": {
        "role": "voorzitter van de Raad van Bestuur",
        "start_date": "2023-04-19"
      },
      "object": "e1",
      "subject": "e14",
      "_value_raw": {
        "role": "voorzitter van de Raad van Bestuur",
        "start_date": "19/04/2023"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. (BE 0403.096.168) heeft als nieuwe vaste vertegenwoordiger vanaf 01/01/2023 de heer Xavier Hormaechea in opvolging van de heer Willy Cnops.",
      "value": {
        "end_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e11"
    },
    {
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. (BE 0403.066.474) heeft als nieuwe vaste vertegenwoordiger vanat 19/01/2023 mevrouw Emmanuelle Boishardy, in opvolging van mevrouw Sabena Solomon.",
      "value": {
        "end_date": "19/01/2023"
      },
      "object": "e4",
      "subject": "e13"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 2632,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca N.V.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": "0419.122.548",
      "kind": "company",
      "name": "KPMG Bedrijfsrevisoren BV",
      "attrs": {
        "seat": "Bourgetlaan 40, 1130 Brussel"
      }
    },
    {
      "id": "e9",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Willy Cnops",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Emmanuelle Boishardy",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sabena Solomon",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : Nouveaux administrateurs et commissaire - nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident",
      "value": "Nouveaux administrateurs et commissaire - nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-05-03",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 03 MEI 2023",
      "value": "03/05/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE ORDINAIRE DU 22 MARS 2023",
      "value": "22/03/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1.AstraZeneca S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2.Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3.GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4.Janssen-Cilag S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 5.Novartis Pharma S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 5.Sanofi Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "auditor_appointment",
      "quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la reconduction de la nomination pour une p\u00E9riode de trois ans du commissaire KPMG R\u00E9viseurs d\u0027Entreprises SRL",
      "value": {
        "role": "commissaire",
        "term": "trois ans",
        "start_date": null
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "date": "2023-01-01",
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. ... a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/01/2023 Monsieur Xavier Hormaechea",
      "value": {
        "start_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2023-01-19",
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. ... a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 19/01/2023 Madame Emmanuelle Boishardy",
      "value": {
        "start_date": "19/01/2023"
      },
      "object": "e12",
      "subject": "e13"
    },
    {
      "date": "2023-04-19",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 19 AVRIL 2023",
      "value": "19/04/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 19 avril 2023, Monsieur Fr\u00E9d\u00E9ric Clais a \u00E9t\u00E9 d\u00E9sign\u00E9 comme Pr\u00E9sident du Conseil d\u0027administration.",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": "e1",
      "subject": "e15",
      "_value_raw": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "term": null,
        "start_date": null
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 2645,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bte 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": "0419.122.548",
      "kind": "company",
      "name": "KPMG R\u00E9viseurs d\u0027Entreprises SRL",
      "attrs": {
        "seat": "avenue du Bourget 40, 1130 Bruxelles"
      }
    },
    {
      "id": "e9",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Willy Cnops",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Emmanuelle Boishardy",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Sabena Solomon",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 819225260.4,
      "currency": "EUR",
      "after_eur": 7804773797.45,
      "delta_eur": 819225260.4,
      "before_eur": 6985548537.05,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-07-15",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital social \u00E0 concurrence de 819.225.260,40 EUR pour le porter de 6.985.548.537,05 EUR \u00E0 7.804.773.797,45 EUR r\u00E9mun\u00E9r\u00E9 par l\u2019\u00E9mission de 98.433.814 nouvelles actions... Ces actions nouvelles seront attribu\u00E9es, enti\u00E8rement lib\u00E9r\u00E9es, \u00E0 la soci\u00E9t\u00E9 anonyme UCB, en r\u00E9mun\u00E9ration de l\u0027apport en nature par cette derni\u00E8re de la note intra-groupe d\u2019un montant total de 819.225.268,29 EUR au 15 juillet 2022",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kirsten Lund-J\u00FCrgensen",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "de renouveler les mandats d\u0027administrateurs de Mesdames Kirsten Lund-J\u00FCrgensen et Caroline Vancoillie pour un terme de six ans"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Caroline Vancoillie",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "de renouveler les mandats d\u0027administrateurs de Mesdames Kirsten Lund-J\u00FCrgensen et Caroline Vancoillie pour un terme de six ans"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Romain Seffer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PwC R\u00E9viseurs d\u0027entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-07-01",
      "evidence_quote": "d\u0027acter la fin du mandat de PwC R\u00E9viseurs d\u0027entreprises SRL, ayant son si\u00E8ge social \u00E0 Woluwedal 18, Sint-Stevens-Woluwe, repr\u00E9sent\u00E9e par Romain Seffer, en qualit\u00E9 de commissaire de la Soci\u00E9t\u00E9 au moment de l\u0027entr\u00E9e en vigueur des pr\u00E9sentes d\u00E9cisions unanimes par \u00E9crit;"
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Anton Nuttens",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0428837889",
        "name": "Mazars R\u00E9viseurs d\u0027Entreprises SC",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-07-01",
      "evidence_quote": "de nommer Mazars R\u00E9viseurs d\u0027Entreprises SC, ayant son si\u00E8ge social \u00E0 Avenue du Boulevard 21, box 8, 1210 Saint-Josse-ten-Noode (Bruxelles) et portant le num\u00E9ro d\u0027entreprise 0428.837.889, comme nouveau commissaire pour une dur\u00E9e de 3 ans, jusqu\u0027\u00E0 et y compris l\u0027assembl\u00E9e g\u00E9n\u00E9rale appel\u00E9e \u00E0 statuer s"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 6985548537.05,
      "currency": "EUR",
      "after_eur": 6985548537.05,
      "delta_eur": 6985548537.05,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2020-12-18",
      "evidence_quote": "ARTICLE 5.- Le capital est fix\u00E9 \u00E0 six milliards neuf cent quatre-vingt-cinq millions cinq cent quarante-huit mille cinq cent trente-sept euros et cinq cents (6.985.548.537,05 EUR) et est repr\u00E9sent\u00E9 par 839.351.526 actions sans d\u00E9signation de valeur nominale, num\u00E9rot\u00E9s de 1 \u00E0 839.351.526 repr\u00E9sentant chacune 1/839.351.526e du capital social, enti\u00E8rement lib\u00E9r\u00E9es.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 5751269288.48,
      "currency": "EUR",
      "after_eur": 6985548537.05,
      "delta_eur": 5751269288.48,
      "before_eur": 1234279248.57,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2020-12-18",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital social \u00E0 concurrence de 5.751.269.288,48 EUR pour le porter de 1.234.279.248,57 EUR \u00E0 6.985.548.537,05 EUR par l\u2019\u00E9mission de 691.046.183 nouvelles actions... Ces actions nouvelles seront attribu\u00E9es, enti\u00E8rement lib\u00E9r\u00E9es, \u00E0 la soci\u00E9t\u00E9 anonyme UCB, en r\u00E9mun\u00E9ration de l\u0027apport par cette derni\u00E8re du billet \u00E0 ordre",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Geoffroy Folie",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-10-19",
      "evidence_quote": "Le Conseil d\u0027Administration d\u00E9cide de nommer, avec effet au 19 octobre 2020, Geoffroy Folie, avec adresse professionnelle, Chemin du Foriest 1 \u00E0 1420 Braine-l\u0027Alleud, en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9 charg\u00E9 de la gestion journali\u00E8re de la soci\u00E9t\u00E9, avec pouvoir d\u0027agir seul, en remplacement de Eric Browaeys dont"
    },
    {
      "kind": "director_out",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Eric Browaeys",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-10-19",
      "evidence_quote": "Le Conseil d\u0027Administration d\u00E9cide de nommer, avec effet au 19 octobre 2020, Geoffroy Folie, avec adresse professionnelle, Chemin du Foriest 1 \u00E0 1420 Braine-l\u0027Alleud, en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9 charg\u00E9 de la gestion journali\u00E8re de la soci\u00E9t\u00E9, avec pouvoir d\u0027agir seul, en remplacement de Eric Browaeys dont"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Christophe Tellier",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "d\u00E9cident de renouveler les mandats d\u0027administrateurs de Messieurs Jean-Christophe Tellier et Charl van Zyl pour un terme de trois ans"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Charl van Zyl",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "d\u00E9cident de renouveler les mandats d\u0027administrateurs de Messieurs Jean-Christophe Tellier et Charl van Zyl pour un terme de trois ans"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Jacques Marbehant",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-11-22",
      "evidence_quote": "Le Conseil d\u0027Administration d\u00E9cide de nommer, avec effet au 22 novembre 2019, Jacques Marbehant, avec adresse professionnelle, Chemin du Foriest 1 \u00E0 1420 Braine-l\u0027Alleud, en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9 charg\u00E9 de la gestion journali\u00E8re de la soci\u00E9t\u00E9, avec pouvoir d\u0027agir seul."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kirsten LUND-J\u00DCRGENSEN",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-07-18",
      "evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 536 \u00A7 1 du Cade des Soci\u00E9t\u00E9s, les actionnaires: d\u00E9cident \u00E0 l\u0027unanimit\u00E9 de nommer, avec effet imm\u00E9diat, Kirsten LUND-J\u00DCRGENSEN, avec adresse! professionnelle, Chemin du Foriest 1 \u00E0 1420 Braine-l\u0027Alleud, en qualit\u00E9 d\u0027Administrateur additionnel de la Soci\u00E9t\u00E9."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "date": "2019-07-09",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 09/07/2019",
      "value": "09/07/2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-06-28",
      "type": "filing",
      "quote": "vangen op 28 JUNI 2019 ter griffie van de Nederlandstalige ondernemingsrechtbank Brusss",
      "value": "28/06/2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-03-27",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 27 MAART 2019",
      "value": "27/03/2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. MSD Belgium N.V.",
      "value": {
        "date": "2019-03-27",
        "role": "Raad van Bestuur"
      },
      "object": null,
      "subject": "e1",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Raad van Bestuur"
      }
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. Roche N.V.",
      "value": {
        "date": "2019-03-27",
        "role": "Raad van Bestuur"
      },
      "object": null,
      "subject": "e2",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Raad van Bestuur"
      }
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3. Chiesi N.V.",
      "value": {
        "date": "2019-03-27",
        "role": "Raad van Bestuur"
      },
      "object": null,
      "subject": "e3",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Raad van Bestuur"
      }
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4. UCB Pharma N.V.",
      "value": {
        "date": "2019-03-27",
        "role": "Raad van Bestuur"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Raad van Bestuur"
      }
    },
    {
      "date": "2019-04-24",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 24 APRIL 2019",
      "value": "24/04/2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-04-24",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 24 april 2019 werd Celgene, vertegenwoordigd door Michel Collard, verkozen tot nieuwe ondervoorzitter van de Raad van Bestuur",
      "value": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "start_date": "2019-04-24"
      },
      "object": null,
      "subject": "e5",
      "_value_raw": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "start_date": "24/04/2019"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "Celgene, vertegenwoordigd door Michel Collard",
      "value": null,
      "object": "e5",
      "subject": "e6"
    },
    {
      "date": "2019-04-24",
      "type": "officer_resignation",
      "quote": "in opvolging van MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
      "value": {
        "date": "2019-04-24",
        "role": "ondervoorzitter van de Raad van Bestuur"
      },
      "object": null,
      "subject": "e1",
      "_value_raw": {
        "date": "24/04/2019",
        "role": "ondervoorzitter van de Raad van Bestuur"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
      "value": null,
      "object": "e1",
      "subject": "e7"
    },
    {
      "type": "officer_appointment",
      "quote": "Catherine Rutten CEO belast met het dagelijks bestuur",
      "value": {
        "role": "CEO belast met het dagelijks bestuur"
      },
      "object": null,
      "subject": "e8"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1672,
    "truncated": false
  },
  "entities": [
    {
      "id": "e0",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
        "legal_form": "Vereniging zonder winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e1",
      "kbo": "0406.820.770",
      "kind": "company",
      "name": "MSD Belgium N.V.",
      "attrs": {
        "seat": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.088.151",
      "kind": "company",
      "name": "Roche N.V.",
      "attrs": {
        "seat": "Dantestraat 75, 1070 Anderlecht"
      }
    },
    {
      "id": "e3",
      "kbo": "0826.654.883",
      "kind": "company",
      "name": "Chiesi N.V.",
      "attrs": {
        "seat": "Telecomlaan 9, 1831 Diegem"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {
        "seat": "Researchdreef 60, 1070 Anderlecht"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "company",
      "name": "Celgene",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Michel Collard",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Clarisse Lhoste",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2019-07-09",
      "type": "publication",
      "quote": "2019 - Annexes du Moniteur belge",
      "value": "2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-05-28",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 28 JUMM 2019",
      "value": "28/05/2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-03-27",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 27 MARS 2019",
      "value": "27/03/2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
      "value": {
        "date": "2019-03-27",
        "role": "Membre du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e1",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Membre du Conseil d\u0027administration"
      }
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2. Roche S.A.",
      "value": {
        "date": "2019-03-27",
        "role": "Membre du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e2",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Membre du Conseil d\u0027administration"
      }
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3. Chiesi S.A.",
      "value": {
        "date": "2019-03-27",
        "role": "Membre du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e3",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Membre du Conseil d\u0027administration"
      }
    },
    {
      "date": "2019-03-27",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4. UCB Belgium S.A.",
      "value": {
        "date": "2019-03-27",
        "role": "Membre du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "date": "27/03/2019",
        "role": "Membre du Conseil d\u0027administration"
      }
    },
    {
      "date": "2019-04-24",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 24 AVRIL 2019",
      "value": "24/04/2019",
      "object": null,
      "subject": null
    },
    {
      "date": "2019-04-24",
      "type": "officer_appointment",
      "quote": "Celgene ... a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident du Conseil d\u0027administration",
      "value": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
        "start_date": "2019-04-24"
      },
      "object": null,
      "subject": "e5",
      "_value_raw": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
        "start_date": "24/04/2019"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "Celgene, repr\u00E9sent\u00E9e par Michel Collard",
      "value": null,
      "object": "e5",
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "MSD Belgium, repr\u00E9sent\u00E9e par Clarisse Lhoste",
      "value": null,
      "object": "e1",
      "subject": "e7"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "postfix": [
      "publication date None -\u003E edition 2019-07-09"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1695,
    "truncated": false
  },
  "entities": [
    {
      "id": "e0",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e1",
      "kbo": "0406.820.770",
      "kind": "company",
      "name": "MSD Belgium S.A.",
      "attrs": {
        "seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.088.151",
      "kind": "company",
      "name": "Roche S.A.",
      "attrs": {
        "seat": "rue Dante 75, 1070 Anderlecht"
      }
    },
    {
      "id": "e3",
      "kbo": "0826.654.883",
      "kind": "company",
      "name": "Chiesi S.A.",
      "attrs": {
        "seat": "Telecomlaan 9, 1831 Diegem"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Belgium S.A.",
      "attrs": {
        "seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "company",
      "name": "Celgene",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Michel Collard",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Clarisse Lhoste",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Cleo Ricci",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-03-31",
      "evidence_quote": "Le Conseil est inform\u00E9 que Cleo Ricci a quitt\u00E9 UCB et accepte sa lettre de d\u00E9mission en qualit\u00E9 d\u0027Adminitrateur et g\u00E9rant charg\u00E9 de la gestion joumali\u00E8re avec effet au 31 mars 2019."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Caroline Vancoillie",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "d\u00E9cident de renouveler le mandat d\u0027administrateur de Madame Caroline Vancoillie pour un terme de trois ans"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 305116347.97,
      "currency": "EUR",
      "after_eur": 1234279248.57,
      "delta_eur": 305116347.97,
      "before_eur": 929162900.6,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-04-29",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital social \u00E0 concurrence de 305.116.347,97 EUR pour le porter de 929.162.900,60 EUR \u00E0 1.234.279.248,57 EUR par l\u2019\u00E9mission de 36.661.383 nouvelles actions... attribu\u00E9es, enti\u00E8rement lib\u00E9r\u00E9es, \u00E0 la soci\u00E9t\u00E9 anonyme UCB, en r\u00E9mun\u00E9ration de l\u0027apport par cette derni\u00E8re d\u0027une partie du pr\u00EAt",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Benoit Stevens",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-04-01",
      "evidence_quote": "Le Conseil est inform\u00E9 que Benoit Stevens a d\u00E9missionn\u00E9 en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion de la Soci\u00E9t\u00E9 \u00E0 partir du 1 avril 2018."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Benoit Stevens",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-04-19",
      "evidence_quote": "d\u00E9mission volontaire de Monsieur Benoit Stevens comme administrateur de la Soci\u00E9t\u00E9 d\u00E8s le 19 avril 2018;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Caroline Vancoillie",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "nomination en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, \u00E0 titre gratuit et prenant fin \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de 2019: Madame Caroline Vancoillie avec adresse personnelle \u00E0 All\u00E9e de la Recherche 60, 1070 Bruxelles."
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Romain Seffer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SCCRL PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "renouvellement du mandat de la SCCRL PwC Reviseurs d\u0027Entreprises, ayant son si\u00E8ge social \u00E0 1932 Sint-Stevens-Woluwe, Woluwedal 18, en qualit\u00E9 de commissaire pour un terme de trois ans. Cette soci\u00E9t\u00E9 d\u00E9signe Monsieur Romain Seffer, r\u00E9viseur d\u0027entreprises, comme repr\u00E9sentant permanent pour la repr\u00E9sen"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Fabrice Enderlin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-05-10",
      "evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 536 du Code des soci\u00E9t\u00E9s, les Actionnaires, \u00E0 l\u0027unanimit\u00E9 sont inform\u00E9s que le mandat de Fabrice Enderiin en qualit\u00E9 d\u0027Administrateur a expir\u00E9 lors de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale du 10 mai 2017."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Christophe Tellier",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "decident de renouveler le mandat d\u0027Administrateur de Jean-ChristopheTellier, avec adresse professionnelle All\u00E9e de la Recherche, 60 \u00E0 1070 Bruxelles pour un terme de tro\u00EDs ans."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Charl van Zyl",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "decident de nommer Charl van Zyl, aveo adresse professionnelle All\u00E9e de la Recherche, 60 \u00E0 1070 Bruxelles, en qualit\u00E9 d\u0027Administrateur pour un terme de trois ans;"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mark McDade",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-12-31",
      "evidence_quote": "Mark McDade prenant sa retraite au sein du Groupe UCB \u00E0 fin d\u00E9cembre, le Conseil est inform\u00E9 qu\u0027il va \u00E9galement d\u00E9missionner en qualit\u00E9 d\u0027Administrateur avec effet au 31 d\u00E9cembre 2016. Le Conseil accepte la d\u00E9m\u00EDssion de Mark McDade en qualit\u00E9 d\u0027Administrateur de la soci\u00E9t\u00E9 avec effet au 31 d\u00E9cembre "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2016-05-11",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch. Staatshlad -11/05/2016-",
      "value": "11/05/2016",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2016-04-29",
      "type": "filing",
      "quote": "neergelegd/entvangen op 29 APR, 2016",
      "value": "29/04/2016",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2016-03-18",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 18 MARS 2016",
      "value": "18/03/2016",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2016-03-18",
      "type": "officer_appointment",
      "quote": "Nomination de: 1. Roche S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2016-03-18"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "18/03/2016"
      }
    },
    {
      "date": "2016-03-18",
      "type": "officer_appointment",
      "quote": "Nomination de: 2. Chiesi S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2016-03-18"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "18/03/2016"
      }
    },
    {
      "date": "2016-03-18",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2016-03-18"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "18/03/2016"
      }
    },
    {
      "date": "2016-03-18",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2. UCB Belgium S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2016-03-18"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "18/03/2016"
      }
    },
    {
      "date": "2016-03-18",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de : 1. AstraZeneca S.A.",
      "value": {
        "date": "2016-03-18",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "date": "18/03/2016",
        "role": "administrateur"
      }
    },
    {
      "date": "2016-03-18",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de : 2. Baxter Belgium SPRL",
      "value": {
        "date": "2016-03-18",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "date": "18/03/2016",
        "role": "administrateur"
      }
    },
    {
      "date": "2016-03-18",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de : 3. Bracco Imaging Europe B.V.",
      "value": {
        "date": "2016-03-18",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "date": "18/03/2016",
        "role": "administrateur"
      }
    },
    {
      "type": "statute_amendment",
      "quote": "article 14. Poids des votes, procuration et proc\u00E9dure de vote",
      "value": {
        "article": "14",
        "description": "Poids des votes, procuration et proc\u00E9dure de vote"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "article 16. Composition",
      "value": {
        "article": "16",
        "description": "Composition du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "article 21. Mandats",
      "value": {
        "article": "21",
        "description": "Mandats"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "Article 27ter. Organes",
      "value": {
        "article": "27ter",
        "description": "Organes (groupe pharma.be animal health)"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "article 33.",
      "value": {
        "article": "33",
        "description": "Conditions d\u0027admission et dur\u00E9e de mandat exceptionnelle"
      },
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 16790,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.088.151",
      "kind": "company",
      "name": "Roche S.A.",
      "attrs": {
        "seat": "rue Dante 75, 1070 Anderlecht"
      }
    },
    {
      "id": "e3",
      "kbo": "0826.654.883",
      "kind": "company",
      "name": "Chiesi S.A.",
      "attrs": {
        "seat": "avenue du Bourget 44, 1130 Haren (Bruxelles)"
      }
    },
    {
      "id": "e4",
      "kbo": "0406.820.770",
      "kind": "company",
      "name": "MSD Belgium S.A.",
      "attrs": {
        "seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
      }
    },
    {
      "id": "e5",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Belgium S.A.",
      "attrs": {
        "seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
      }
    },
    {
      "id": "e6",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {
        "seat": "rue Egide Van Ophem 110, 1180 Uccle"
      }
    },
    {
      "id": "e7",
      "kbo": "0861.155.805",
      "kind": "company",
      "name": "Baxter Belgium SPRL",
      "attrs": {
        "seat": "boulevard d\u0027Angleterre 2-4, 1420 Braine l\u0027Alleud"
      }
    },
    {
      "id": "e8",
      "kbo": "0892.349.322",
      "kind": "company",
      "name": "Bracco Imaging Europe B.V.",
      "attrs": {
        "seat": "avenue Pasteur 6, 1300 Wavre"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {
        "role": "CEO charg\u00E9 de la gestion journali\u00E8re"
      }
    }
  ]
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Anna S. Richo",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-01-15",
      "evidence_quote": "1.acceptent les d\u00E9m\u00EDssions, avec effet imm\u00E9diat, de Anna S. Richo, Ismail Kola et de Detlef Thielgen en qualit\u00E9 d\u0027Administrateurs;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ismail Kola",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-01-15",
      "evidence_quote": "1.acceptent les d\u00E9m\u00EDssions, avec effet imm\u00E9diat, de Anna S. Richo, Ismail Kola et de Detlef Thielgen en qualit\u00E9 d\u0027Administrateurs;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Detlef Thielgen",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-01-15",
      "evidence_quote": "1.acceptent les d\u00E9m\u00EDssions, avec effet imm\u00E9diat, de Anna S. Richo, Ismail Kola et de Detlef Thielgen en qualit\u00E9 d\u0027Administrateurs;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Benoit Stevens",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-01-15",
      "evidence_quote": "2.d\u00E9cident de nommer, avec effet imm\u00E9diat, Benoit Stevens, domicili\u00E9 rue Alexis Willems 28, 1160 Auderghem, et Cleo Ricci, domicili\u00E9 rue des Aub\u00E9pines 10 \u00E0 7380 Qui\u00E9vrain, en qualit\u00E9 d\u0027Administrateurs pour: un terme de trois ans."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Cleo Ricci",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-01-15",
      "evidence_quote": "2.d\u00E9cident de nommer, avec effet imm\u00E9diat, Benoit Stevens, domicili\u00E9 rue Alexis Willems 28, 1160 Auderghem, et Cleo Ricci, domicili\u00E9 rue des Aub\u00E9pines 10 \u00E0 7380 Qui\u00E9vrain, en qualit\u00E9 d\u0027Administrateurs pour: un terme de trois ans."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.096.168",
    "name_full": "UCB PHARMA",
    "legal_form": "SA"
  }
}